Selective COX-2-inhibition by Rofecobix reduces the risk of severe gastrointestinal complications by 50%

Authors
Kellner, H
Citation
H. Kellner, Selective COX-2-inhibition by Rofecobix reduces the risk of severe gastrointestinal complications by 50%, Z GASTROENT, 39(5), 2001, pp. 443-445
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
ZEITSCHRIFT FUR GASTROENTEROLOGIE
ISSN journal
00442771 → ACNP
Volume
39
Issue
5
Year of publication
2001
Pages
443 - 445
Database
ISI
SICI code
0044-2771(200105)39:5<443:SCBRRT>2.0.ZU;2-F